News

Vietnam is accelerating efforts to strengthen economic resilience through targeted reforms, digital transformation, and the ...
The US Dollar (USD) halted a four-week winning streak, coming under renewed and significant selling pressure to hit fresh ...
Iranian Foreign Minister Abbas Araghchi said on Friday that discussions with the United States (US) over its nuclear program ...
Oklo stock surged on nuclear support and data center demand, but remains speculative with tech, capital, and regulatory risks ...
Moody's posted strong Q1 results and looks poised to outperform lowered guidance as market conditions improve. Find out why ...
U.S. homeowners are boosting spending on home renovation projects, bucking a broader pullback by consumers amid diminished ...
Polen Capital, an investment management company, released its “Polen Global Growth Strategy” first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
The gross proceeds from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Outlook Therapeutics are expected to be approximately $13.0 million.
Public Debt Office and analysts confirm inflows are long-term investment, not 'hot money', despite economic fragility; US ...
Mayor Mike Johnston said the city is facing a revenue gap of about $50 million this year, and about a $200 million projected ...
EnerSys’ stock price declined over 16% at the open of the markets Thursday morning and closed the day down 14.89%.